OBJECTIVE: To design clear guidelines for the staging and follow-up of patients with ovarian cancer, and to provide the radiologist with a framework for use in multidisciplinary conferences. METHODS: Guidelines for ovarian cancer staging and follow-up were defined by the female imaging subcommittee of the ESUR (European Society of Urogenital Radiology) based on the expert consensus of imaging protocols of 12 leading institutions and a critical review of the literature. RESULTS: Computed tomography (CT) with coverage of the base of the lungs to the inguinal region is regarded as the imaging technique of choice for preoperative staging. Critical diagnostic criteria are presented and the basis for a structured report for preoperative staging is outlined. Following primary treatment for ovarian cancer, clinical assessment and CA-125 are routinely used to monitor patients. For suspected recurrence, CT remains the imaging modality of choice, with positron emission tomography (PET)/CT emerging as the optimal imaging technique for suspected recurrence, particularly in patients with negative CT or magnetic resonance imaging (MRI). CONCLUSIONS: CT is the imaging modality of choice for preoperative staging and detection of recurrence in patients with ovarian cancer.
OBJECTIVE: To design clear guidelines for the staging and follow-up of patients with ovarian cancer, and to provide the radiologist with a framework for use in multidisciplinary conferences. METHODS: Guidelines for ovarian cancer staging and follow-up were defined by the female imaging subcommittee of the ESUR (European Society of Urogenital Radiology) based on the expert consensus of imaging protocols of 12 leading institutions and a critical review of the literature. RESULTS: Computed tomography (CT) with coverage of the base of the lungs to the inguinal region is regarded as the imaging technique of choice for preoperative staging. Critical diagnostic criteria are presented and the basis for a structured report for preoperative staging is outlined. Following primary treatment for ovarian cancer, clinical assessment and CA-125 are routinely used to monitor patients. For suspected recurrence, CT remains the imaging modality of choice, with positron emission tomography (PET)/CT emerging as the optimal imaging technique for suspected recurrence, particularly in patients with negative CT or magnetic resonance imaging (MRI). CONCLUSIONS: CT is the imaging modality of choice for preoperative staging and detection of recurrence in patients with ovarian cancer.
Authors: A B Kurtz; J V Tsimikas; C M Tempany; U M Hamper; P H Arger; R L Bree; R J Wechsler; I R Francis; J E Kuhlman; E S Siegelman; D G Mitchell; S G Silverman; D L Brown; S Sheth; B G Coleman; J H Ellis; R J Kurman; D J Caudry; B J McNeil Journal: Radiology Date: 1999-07 Impact factor: 11.105
Authors: Mannudeep K Kalra; Michael M Maher; Thomas L Toth; Bernhard Schmidt; Bryan L Westerman; Hugh T Morgan; Sanjay Saini Journal: Radiology Date: 2004-10-21 Impact factor: 11.105
Authors: Nyree Griffin; Lee A Grant; Susan J Freeman; Mercedes Jimenez-Linan; Laurence H Berman; Helena Earl; Ahmed Ashour Ahmed; Robin Crawford; James Brenton; Evis Sala Journal: Eur Radiol Date: 2008-08-15 Impact factor: 5.315
Authors: U Wagner; P Harter; F Hilpert; S Mahner; A Reuß; A du Bois; E Petru; W Meier; P Ortner; K König; K Lindel; D Grab; P Piso; O Ortmann; I Runnebaum; J Pfisterer; D Lüftner; N Frickhofen; F Grünwald; B O Maier; J Diebold; S Hauptmann; F Kommoss; G Emons; B Radeleff; M Gebhardt; N Arnold; G Calaminus; I Weisse; J Weis; J Sehouli; D Fink; A Burges; A Hasenburg; C Eggert Journal: Geburtshilfe Frauenheilkd Date: 2013-09 Impact factor: 2.915
Authors: Francesca De Piano; Valentina Buscarino; Dulia Maresca; Patrick Maisonneuve; Giovanni Aletti; Roberta Lazzari; Andrea Vavassori; Massimo Bellomi; Stefania Rizzo Journal: Radiol Med Date: 2019-08-31 Impact factor: 3.469
Authors: Katrijn Michielsen; Ignace Vergote; Katya Op de Beeck; Frederic Amant; Karin Leunen; Philippe Moerman; Christophe Deroose; Geert Souverijns; Steven Dymarkowski; Frederik De Keyzer; Vincent Vandecaveye Journal: Eur Radiol Date: 2013-12-11 Impact factor: 5.315
Authors: H A Vargas; I A Burger; D A Goldman; M Miccò; R E Sosa; W Weber; D S Chi; H Hricak; E Sala Journal: Eur Radiol Date: 2015-04-28 Impact factor: 5.315